the aid library

LIST OPTIONS

Filter

27750

Tuberculosis action plan for the WHO European Region, 2023–2030

World Health Organisation (WHO) (2023) C_WHO

Tuberculosis (‎TB)‎ and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monitoring and evaluation framework and outlines the visi... more

Download (237)

View PDF (320)

Self-care interventions for sexual and reproductive health and rights to advance universal health coverage: 2023 joint statement by HRP, WHO, UNDP, UNFPA and the World Bank

World Health Organisation (WHO) (2023) C_WHO

According to the latest available data, over half of the world’s population lack access to essential health services, and health worker shortages are estimated to reach 10 million by 2030. These contextual factors point to an urgent need to explore innovative strategies – that go beyond a conven... more

Download (173)

View PDF (318)

Interventions d’autogestion de la santé et des droits sexuels et reproductifs pour faire progresser la couverture sanitaire universelle
recommended

World Health Organisation (WHO) (2023) C_WHO

Les interventions d’autosoins offrent un énorme potentiel pour renforcer l’action individuelle et réduire les inégalités en matière de santé en augmentant la disponibilité d’options de soins de santé accessibles, acceptables et abordables qui s’ajoutent aux services et soins reçus ... more

Intervenciones de autocuidado para la salud y los derechos sexuales y reproductivos a fin de avanzar con la cobertura sanitaria universal:

World Health Organisation (WHO) (2023) C_WHO

Las intervenciones de autocuidado ofrecen un enorme potencial para mejorar la autonomía individual y reducir las desigualdades sanitarias al aumentar la disponibilidad de opciones de atención sanitaria accesibles, aceptables y asequibles que se suman a los servicios y la atención recibidos en u... more

World Disasters Report 2022: Executive Summary

International Federation of Red Cross and Red Crescent Societies IFR (2023) CC

The COVID-19 pandemic has been the biggest disaster in living memory, on almost any measure. More than 6.5 million people are confirmed to have died in less than three years, and the pandemic’s indirect impacts have touched the lives of virtually every community on the planet. Our World Disasters... more

External Link

Climate Risk Sourcebook

Deutsche Gesellschaft für Internationale Zusammenarbeit GIZ; Eurac Research; United Nations University (2023) CC

Climate change is one of the most urgent challenges for people and ecosystems worldwide. The recently published sixth Assessment Report (AR6) of the Intergovernmental Panel on Climate Change (IPCC) stresses the occurrence of widespread adverse impacts of climate change. Increased frequency and inten... more

External Link

How to Survive Extreme Heat Posters in English (Simple, Senior Friendly Poster)

Climate Psychiatry Alliance (2023) CC

How to Survive Extreme Heat Posters in English (Simple, Senior Friendly Poster)

External Link

How to Survive Extreme Heat Posters in English (Detailed poster)

Climate Psychiatry Alliance (2023) CC

How to Survive Extreme Heat Posters in English (Detailed poster)

External Link

IRC Health Strategy 2023-2027

International Rescue Committee (2023) CC

The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr... more

Download (97)

View PDF (120)

Sudan: Gender Tip Sheets – Health

Health ClusterUN Women (2023) CC

Needs assessment and analysis Collect and analyze sex, age and disability disaggregated data (SADDD) and conduct a participatory gender analysis to understand different health needs, capacities, barriers and aspirations and identify populations with special health requirements Population demogra... more

Download (146)

View PDF (139)

WHO Guide to conducting programme reviews for HIV, viral hepatitis and sexually transmitted infections

World Health Organization WHO (2023) C_WHO

Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diverse needs, enables efficient use of health system re... more

External Link

Number of recorded natural disaster events 1900-2023

Our World in Data (2023) CC

The number of global reported natural disaster events in any given year. Note that this largely reflects increases in data reporting, and should notbe used to assess the total number of events.

Operational framework for building climate resilient and low carbon health systems

World Health Organization WHO (2023) C_WHO

This document presents the World Health Organization Operational framework for building climate resilient and low carbon health systems*. ***The framework's goal is to increase the climate resilience of health systems to protect and improve the health of communities in an unstable and changing clima... more

Download (157)

View PDF (166)

Pre-referral treatment with rectal artesunate of children with suspected severe malaria: a field guide

World Health Organization WHO (2023) C_WHO

Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a... more

Download (288)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Analysis and use of health facility data: guidance for maternal, newborn, child and adolescent health programme managers

World Health Organisation (WHO) (2023) C_WHO

This guidance describes a catalogue of indicators for maternal, newborn, child and adolescent health (MNCAH) that can be monitored through health management information system data. It is a module of the WHO Toolkit for Routine Health Information Systems (RHIS) Data and links to relevant indicators ... more

Download (130)

View PDF (136)

Roadmap towards ending TB in children and adolescents, 3rd ed

World Health Organisation (WHO) (2023) C_WHO

The Roadmap towards ending TB among children and adolescents, third edition builds on the 2013 and 2018 versions. The 2023 version recognizes the progress made over the past five years and outlines priorities and key actions designed to accelerate progress towards the targets elaborated during the 2... more

Managing epidemics: key facts about major deadly diseases, 2nd edition

World Health Organisation (WHO) (2023) C_WHO

Epidemics and pandemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of new... more

Managing epidemics: key facts about major deadly diseases, 2nd edition

World Health Organisation (WHO) (2023) C_WHO

Zanzibar's victory against Cholera Epidemic

World Health Organization WHO (2023) C_WHO

Response to the Periodic Epidemic

Interventions d’autogestion de la santé et des droits sexuels et reproductifs pour faire progresser la couverture sanitaire universelle recommended

Interventions d’autogestion de la santé et des droits sexuels et reproductifs pour faire progresser la couverture sanitaire universelle
recommended